Entrada Therapeutics Inc. (TRDA)
TRDA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.86
-11.64% on the day
Market cap
$189.2M
Micro cap
Revenue · 2025
$25.4M
-87.9% on 2024
Net income · 2025
-$143.8M
-565.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | TRDA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001689375 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $25.4M |
| Net income | -$143.8M |
| Operating income | -$157.9M |
| Net margin | -565.5% |
| Operating margin | -621.1% |
| Revenue growth | -87.9% |
| Cash | $90.4M |
| Total assets | $377.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 7.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3 | S-3 | 2025-11-06 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-10-14 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 472 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ELDN | Eledon Pharmaceuticals Inc. | $2.34 | -4.10% | $190.2M |
| UPB | Upstream Bio Inc. | $3.55 | -14.87% | $194.4M |
| LYEL | Lyell Immunopharma Inc. | $7.51 | -9.19% | $184.0M |
| SION | Sionna Therapeutics Inc. | $4.38 | -6.61% | $198.0M |
| RNAC | Cartesian Therapeutics Inc. | $6.57 | -6.01% | $198.8M |
| ORMP | Oramed Pharmaceuticals Inc. | $4.17 | -2.34% | $173.5M |
| NGEN | NervGen Pharma Corp. | $1.63 | -5.78% | $173.5M |
| PEPG | PepGen Inc. | $2.50 | +0.40% | $173.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier